Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CTI BioPharma Corp.

    NASDAQ: CTIC · Real-Time Price · USD
    9.10
    0.01 (0.11%)
    At close: Jun 23, 2023, 9:58 PM

    CTI BioPharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 53.95M n/a
    Cost of Revenue
    		 3.51M 161K
    Gross Profit
    		 50.43M -161K
    Operating Income
    		 -79.8M -95.33M
    Interest Income
    		 1.68M 38K
    Pretax Income
    		 -92.99M -97.91M
    Net Income
    		 -91.04M -99.64M
    Selling & General & Admin
    		 84.83M 56.2M
    Research & Development
    		 36.9M 39.14M
    Other Expenses
    		 8.51M -161K
    Operating Expenses
    		 130.23M 95.33M
    Interest Expense
    		 13.14M 2.42M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 133.75M 95.33M
    Income Tax Expense
    		 -1.95M 1.73M
    Shares Outstanding (Basic)
    		 114.69M 90.12M
    Shares Outstanding (Diluted)
    		 114.69M 90.12M
    EPS (Basic)
    		 -0.79 -1.11
    EPS (Diluted)
    		 -0.79 -1.11
    EBITDA
    		 -79.85M -95.33M
    EBIT
    		 -79.85M -95.49M
    Depreciation & Amortization
    		 -56K -161K

    Add to Watchlist